Cargando…

Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation

PURPOSE: Intradetrusor onabotulinum toxin A (BTXA) and sacral neuromodulation (SNM) are effective third-line therapies for overactive bladder (OAB). We aimed to measure the outcomes of BTXA for treatment of OAB refractory to initial SNM and identify patient characteristics associated with these outc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trinh, Hamilton, Irish, Vicki, Diaz, Mireya, Atiemo, Humphrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Continence Society 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790822/ https://www.ncbi.nlm.nih.gov/pubmed/31607102 http://dx.doi.org/10.5213/inj.1938030.015

Ejemplares similares

Intradetrusor Injections of Onabotulinum Toxin-A in Children With Urinary Incontinence due to Neurogenic Detrusor Overactivity Refractory to Antimuscarinic Treatment
por: Tarcan, Tufan, et al.
Publicado: (2014)

Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity
por: Rohrsted, Malene, et al.
Publicado: (2012)

Intradetrusor botulinum toxin type A in refractory overactive bladder: A potential future treatment
por: Mahajan, Rajiv, et al.
Publicado: (2011)

A comparative study between sacral neuromodulation and intravesical botulinum toxin injection for patients with refractory overactive bladder
por: Al-Azzawi, Issam S., et al.
Publicado: (2020)

Sleep disturbance changes in women after treatment of refractory overactive bladder with sacral neuromodulation
por: Sanderson, Derrick J., et al.
Publicado: (2020)

Onabotulinum Toxin A Intradetrusor Injections in Children with Neurogenic Lower Urinary Tract Dysfunction: Long-Term Histological Effects on the Bladder Wall
por: Pellegrino, Chiara, et al.
Publicado: (2023)

Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
por: Cohen, Brian L., et al.
Publicado: (2009)

Sacral neuromodulation in overactive bladder: a review and current perspectives
por: Sukhu, Troy, et al.
Publicado: (2016)

Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients
por: Reekmans, Mathias, et al.
Publicado: (2021)

Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance
por: Poole, Ruth Louise, et al.
Publicado: (2021)

Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study
por: Kaaki, Bilal, et al.
Publicado: (2020)

Effects of Acute Sacral Neuromodulation at Different Frequencies on Bladder Overactivity in Pigs
por: Li, Xing, et al.
Publicado: (2017)

Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder
por: Zhang, Yaoguang, et al.
Publicado: (2021)

Effects of Acute Sacral Neuromodulation at Different Pulse Widths on Bladder Overactivity in Pigs
por: Cong, Huiling, et al.
Publicado: (2019)

Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems
por: Meng, Lingfeng, et al.
Publicado: (2022)

Using electroacupuncture with optimized acupoint positioning to predict the efficacy of sacral neuromodulation of refractory overactive bladder: A case report
por: Shen, Jianwu, et al.
Publicado: (2019)

Reduced versus standard intradetrusor OnabotulinumtoxinA injections for treatment of overactive bladder
por: DiCarlo‐Meacham, Angela M., et al.
Publicado: (2022)

Do Failure of Posterior Tibial Nerve Stimulation Precludes to Use Sacral Neuromodulation in Patient With Overactive Bladder?
por: Berthelot, Louis-Paul, et al.
Publicado: (2019)

Variable frequency stimulation of sacral neuromodulation in black-zone overactive bladder patients: a case report
por: Meng, Lingfeng, et al.
Publicado: (2020)

von Brunn's Nests and Follicular Cystitis Following Intradetrusor OnabotulinumtoxinA Injections for Overactive Bladder
por: Nekkanti, Silpa, et al.
Publicado: (2017)

Acute effect of sacral neuromodulation for treatment of detrusor overactivity on urodynamic parameters
por: Groenendijk, Ilse M., et al.
Publicado: (2019)

Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
por: Averbeck, Marcio Augusto
Publicado: (2022)

Refractory Sexual Arousal Subsequent to Sacral Neuromodulation
por: Zoorob, Dani, et al.
Publicado: (2019)

Refractory overactive bladder patients who chose sacral neuromodulation therapy after failed OnabotulinumtoxinA treatment: A systematic review and meta-analysis
por: Yang, Guang, et al.
Publicado: (2020)

Two‐year safety and efficacy outcomes for the treatment of overactive bladder using a long‐lived rechargeable sacral neuromodulation system
por: Blok, Bertil, et al.
Publicado: (2020)

Neuromodulation – a therapeutic option for refractory overactive bladder. A recent literature review
por: Szymański, Jacek K., et al.
Publicado: (2019)

Long-term outcome of sacral neuromodulation for chronic refractory constipation
por: Maeda, Yasuko, et al.
Publicado: (2017)

Learning Curve of Botulinum Toxin Bladder Injection for the Treatment of Refractory Overactive Bladder
por: Barba, Marta, et al.
Publicado: (2022)

Intradetrusor OnabotuliniumtoxinA injection for refractory bladder spasms before vesicovaginal fistula repair
por: Sirls, Evan, et al.
Publicado: (2022)

Sacral Neuromodulation for Bladder Atony – A Case Report()
por: Sujka, Joseph, et al.
Publicado: (2014)

Editorial Comment: Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity
por: Averbeck, Marcio Augusto
Publicado: (2021)

Pelvic Electrical Neuromodulation for the Treatment of Overactive Bladder Symptoms
por: Al-Shaiji, Tariq F., et al.
Publicado: (2011)

A comparison of sacral neuromodulation vs. transvaginal electrical stimulation for the treatment of refractory overactive bladder: the impact on quality of life, body image, sexual function, and emotional well-being
por: La Rosa, Valentina Lucia, et al.
Publicado: (2019)

Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder
por: Zhong, Hui, et al.
Publicado: (2022)

Sacral neuromodulation in children and adolescents with chronic constipation refractory to conservative treatment
por: van der Wilt, Aart A., et al.
Publicado: (2016)

Sacral Neuromodulation for Refractory Bladder Pain Syndrome/Interstitial Cystitis: a Global Systematic Review and Meta-analysis
por: Wang, Junpeng, et al.
Publicado: (2017)

Efficacy and safety of intradetrusor onabotulinumtoxinA injection for managing paediatric non-neurogenic overactive bladder: A prospective case-series study
por: El-Dakhakhny, Amr S., et al.
Publicado: (2019)

Time of onset and factors associated with delayed response post intradetrusor injection of onabotulinumtoxin a in patients with neurogenic and idiopathic overactive bladder syndrome
por: Al-Shaiji, Tariq Faisal, et al.
Publicado: (2023)

Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study
por: García-Azorín, David, et al.
Publicado: (2022)

Is Sacral Neuromodulation a Treatment Option for Primary Bladder Neck Obstruction?
por: Alzahrani, Ibrahim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kalugtiprvfslljbiclf5v1v23